Volume | 228,209 |
|
|||||
News | - | ||||||
Day High | 0.229 | Low High |
|||||
Day Low | 0.21 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Azitra Inc | AZTR | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.2205 | 0.21 | 0.229 | 0.2201 | 0.2249 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
549 | 228,209 | $ 0.2149182 | $ 49,046 | - | 0.1605 - 5.18 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
20:00:00 | 100 | $ 0.2201 | USD |
Azitra Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.66M | 12.10M | - | 686k | -12.64M | -1.04 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Azitra News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AZTR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.209 | 0.24 | 0.18 | 0.2128673 | 952,687 | 0.0149 | 7.13% |
1 Month | 0.205 | 0.26 | 0.1605 | 0.2067987 | 786,265 | 0.0189 | 9.22% |
3 Months | 1.27 | 1.27 | 0.1605 | 0.2385821 | 719,811 | -1.05 | -82.37% |
6 Months | 1.49 | 2.28 | 0.1605 | 0.2927316 | 349,015 | -1.27 | -84.97% |
1 Year | 4.26 | 5.18 | 0.1605 | 0.4378436 | 211,831 | -4.04 | -94.74% |
3 Years | 4.26 | 5.18 | 0.1605 | 0.4378436 | 211,831 | -4.04 | -94.74% |
5 Years | 4.26 | 5.18 | 0.1605 | 0.4378436 | 211,831 | -4.04 | -94.74% |
Azitra Description
Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease. |